Literature DB >> 29174526

Timed function tests, motor function measure, and quantitative thigh muscle MRI in ambulant children with Duchenne muscular dystrophy: A cross-sectional analysis.

Simone Schmidt1, Patricia Hafner2, Andrea Klein3, Daniela Rubino-Nacht4, Vanya Gocheva4, Jonas Schroeder4, Arjith Naduvilekoot Devasia4, Stephanie Zuesli4, Guenther Bernert5, Vincent Laugel6, Clemens Bloetzer7, Maja Steinlin8, Andrea Capone9, Monika Gloor10, Patrick Tobler4, Tanja Haas10, Oliver Bieri10, Thomas Zumbrunn11, Dirk Fischer12, Ulrike Bonati1.   

Abstract

The development of new therapeutic agents for the treatment of Duchenne muscular dystrophy has put a focus on defining outcome measures most sensitive to capture treatment effects. This cross-sectional analysis investigates the relation between validated clinical assessments such as the 6-minute walk test, motor function measure and quantitative muscle MRI of thigh muscles in ambulant Duchenne muscular dystrophy patients, aged 6.5 to 10.8 years (mean 8.2, SD 1.1). Quantitative muscle MRI included the mean fat fraction using a 2-point Dixon technique, and transverse relaxation time (T2) measurements. All clinical assessments were highly significantly inter-correlated with p < 0.001. The strongest correlation with the motor function measure and its D1-subscore was shown by the 6-minute walk test. Clinical assessments showed no correlation with age. Importantly, quantitative muscle MRI values significantly correlated with all clinical assessments with the extensors showing the strongest correlation. In contrast to the clinical assessments, quantitative muscle MRI values were highly significantly correlated with age. In conclusion, the motor function measure and timed function tests measure disease severity in a highly comparable fashion and all tests correlated with quantitative muscle MRI values quantifying fatty muscle degeneration.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  6-minute walk distance; 6-minute walk test; Duchenne muscular dystrophy; Imaging biomarkers; Motor function measure; Quantitative MRI; Timed function tests

Mesh:

Year:  2017        PMID: 29174526     DOI: 10.1016/j.nmd.2017.10.003

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  10 in total

Review 1.  Advancements in magnetic resonance imaging-based biomarkers for muscular dystrophy.

Authors:  Doris G Leung
Journal:  Muscle Nerve       Date:  2019-05-14       Impact factor: 3.217

2.  Quantitative Muscle MRI Protocol as Possible Biomarker in Becker Muscular Dystrophy.

Authors:  Lorenzo Maggi; Marco Moscatelli; Rita Frangiamore; Federica Mazzi; Mattia Verri; Alberto De Luca; Maria Barbara Pasanisi; Giovanni Baranello; Irene Tramacere; Luisa Chiapparini; Maria Grazia Bruzzone; Renato Mantegazza; Domenico Aquino
Journal:  Clin Neuroradiol       Date:  2020-01-23       Impact factor: 3.649

3.  Leveraging cardiac magnetic resonance imaging to assess skeletal muscle progression in Duchenne muscular dystrophy.

Authors:  Jacob A Kaslow; Andrew G Sokolow; Thomas Donnelly; Maciej S Buchowski; Bruce M Damon; Larry W Markham; W Bryan Burnette; Jonathan H Soslow
Journal:  Neuromuscul Disord       Date:  2022-02-04       Impact factor: 3.538

4.  Accelerometric outcomes of motor function related to clinical evaluations and muscle involvement in dystrophic dogs.

Authors:  Mutsuki Kuraoka; Yuko Nitahara-Kasahara; Hisateru Tachimori; Naohiro Kato; Hiroyuki Shibasaki; Akihiko Shin; Yoshitsugu Aoki; En Kimura; Shin'ichi Takeda
Journal:  PLoS One       Date:  2018-12-11       Impact factor: 3.240

5.  MRI Assessment of Motor Capabilities in Patients with Duchenne Muscular Dystrophy According to the Motor Function Measure Scale.

Authors:  Vasily Suslov; Galina Suslova; Sergey Lytaev
Journal:  Tomography       Date:  2022-04-01

6.  Utilization of T1-Mapping for the pelvic and thigh muscles in Duchenne Muscular Dystrophy: a quantitative biomarker for disease involvement and correlation with clinical assessments.

Authors:  Fei Peng; Huayan Xu; Yu Song; Ke Xu; Shuhao Li; Xiaotang Cai; Yingkun Guo; Lianggeng Gong
Journal:  BMC Musculoskelet Disord       Date:  2022-07-16       Impact factor: 2.562

7.  Quantitative muscle MRI biomarkers in Duchenne muscular dystrophy: cross-sectional correlations with age and functional tests.

Authors:  Sarah P Sherlock; Yao Zhang; Michael Binks; Shannon Marraffino
Journal:  Biomark Med       Date:  2021-06-22       Impact factor: 2.851

8.  Platelet Derived Growth Factor-AA Correlates With Muscle Function Tests and Quantitative Muscle Magnetic Resonance in Dystrophinopathies.

Authors:  Alicia Alonso-Jiménez; Esther Fernández-Simón; Daniel Natera-de Benito; Carlos Ortez; Carme García; Elena Montiel; Izaskun Belmonte; Irene Pedrosa; Sonia Segovia; Patricia Piñol-Jurado; Ana Carrasco-Rozas; Xavier Suárez-Calvet; Cecilia Jimenez-Mallebrera; Andrés Nascimento; Jaume Llauger; Claudia Nuñez-Peralta; Paula Montesinos; Jorge Alonso-Pérez; Eduard Gallardo; Isabel Illa; Jordi Díaz-Manera
Journal:  Front Neurol       Date:  2021-06-11       Impact factor: 4.003

9.  Tamoxifen in Duchenne muscular dystrophy (TAMDMD): study protocol for a multicenter, randomized, placebo-controlled, double-blind phase 3 trial.

Authors:  Sara Nagy; Patricia Hafner; Simone Schmidt; Daniela Rubino-Nacht; Sabine Schädelin; Oliver Bieri; Dirk Fischer
Journal:  Trials       Date:  2019-11-21       Impact factor: 2.279

10.  Intraepineurial fat quantification and cross-sectional area analysis of the sciatic nerve using MRI in Charcot-Marie-Tooth disease type 1A patients.

Authors:  Hyun Su Kim; Ji Hyun Lee; Young Cheol Yoon; Min Jae Cha; Soo Hyun Nam; Hye Mi Kwon; Seonwoo Kim; Hojeong Won; Byung-Ok Choi
Journal:  Sci Rep       Date:  2021-11-02       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.